These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26875950)

  • 21. Long-Acting Reversible Contraception for Adolescents: A Review.
    Francis JKR; Gold MA
    JAMA Pediatr; 2017 Jul; 171(7):694-701. PubMed ID: 28558091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
    Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving cost-neutrality with long-acting reversible contraceptive methods.
    Trussell J; Hassan F; Lowin J; Law A; Filonenko A
    Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting reversible contraception: A route to reproductive justice or injustice.
    Kaitz M; Mankuta D; Mankuta L
    Infant Ment Health J; 2019 Sep; 40(5):673-689. PubMed ID: 31329311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multilevel Barriers to Long-Acting Reversible Contraceptive Uptake: A Narrative Review.
    Goldin Evans M; Gee RE; Phillippi S; Sothern M; Theall KP; Wightkin J
    Health Promot Pract; 2024 Jul; 25(4):717-725. PubMed ID: 37978809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Acting Reversible Contraception: An Essential Guide for Pediatric Primary Care Providers.
    Allen S; Barlow E
    Pediatr Clin North Am; 2017 Apr; 64(2):359-369. PubMed ID: 28292451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the uptake of long acting reversible contraception: a review.
    Michie L; Cameron ST
    Minerva Ginecol; 2013 Jun; 65(3):241-52. PubMed ID: 23689167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
    Eeckhaut MCW; Rendall MS; Zvavitch P
    Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Highly Effective Reversible Contraception in Title X Clinics: Variation by Selected State Characteristics.
    Hale N; Khoury A; Smith M
    Womens Health Issues; 2018; 28(4):289-296. PubMed ID: 29661696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting reversible contraception for adolescents.
    McNicholas C; Peipert JF
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):293-8. PubMed ID: 22781078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review.
    Marmett B; Guaranha DDFK; Carvalho AF; Reis JM; Souza CLE; Dalcin TC; Amantéa SL
    J Pediatr Adolesc Gynecol; 2024 Feb; 37(1):11-17. PubMed ID: 37802383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of perceived contraceptive policy changes on long acting reversible contraception dispensing trends.
    Sridhar A; Friedman SR; Sim MK; Troung W; Elias S
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):58-61. PubMed ID: 33198521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective, recommended, underutilized: a review of the literature on barriers to adolescent usage of long-acting reversible contraceptive methods.
    Coles CB; Shubkin CD
    Curr Opin Pediatr; 2018 Oct; 30(5):683-688. PubMed ID: 30028744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.